Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. (öffnet neues Fenster)

Brady KM, Easley RB, Tobias JD.

Quelle‎: Paediatr Anaesth 2006;16(10):1042-6.

Indiziert‎: PubMed 16972833

DOI‎: 10.1111/j.1460-9592.2006.02039.x

https://www.ncbi.nlm.nih.gov/pubmed/16972833 (öffnet neues Fenster)

The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. (öffnet neues Fenster)

Cetin H, Yalaz M, Akisu M, Karapinar DY, Kavakli K, Kultursay N.

Quelle‎: Blood Coagul Fibrinolysis 2006;17(3):213-6.

Indiziert‎: PubMed 16575260

DOI‎: 10.1097/01.mbc.0000220245.20036.2d

https://www.ncbi.nlm.nih.gov/pubmed/16575260 (öffnet neues Fenster)

The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. (öffnet neues Fenster)

Chuansumrit A, Nuntnarumit P, Okascharoen C, Teeraratkul S, Suwansingh S, Supapannachart S.

Quelle‎: Pediatrics 2002;110(1 Pt 1):169-71.

Indiziert‎: PubMed 12093965

https://www.ncbi.nlm.nih.gov/pubmed/12093965 (öffnet neues Fenster)

Recombinant activated factor VIIa (rFVIIa) treatment in very-low-birth-weight (VLBW) premature infants with acute pulmonary hemorrhage: a single-center, retrospective study. (öffnet neues Fenster)

Cosar H, Isik H, Cakır SC, Yar N, Goksen B, Tokbay H, Kertmen H, Erdoğan N, Durak I.

Quelle‎: Paediatr Drugs 2017;19(1):53-8.

Indiziert‎: PubMed 27826851

DOI‎: 10.1007/s40272-016-0203-3

https://www.ncbi.nlm.nih.gov/pubmed/27826851 (öffnet neues Fenster)

Recombinant activated factor VIIa treatment for refractory hemorrhage in infants. (öffnet neues Fenster)

Dang CN, Katakam LI, Smith PB, Cotten CM, Goldberg RN, Chandler N, Thornburg CD, Bidegain M.

Quelle‎: J Perinatol 2011;31(3):188-92.

Indiziert‎: PubMed 20671714

DOI‎: 10.1038/jp.2010.85

https://www.ncbi.nlm.nih.gov/pubmed/20671714 (öffnet neues Fenster)

Use of recombinant factor VIIa in infants with severe coagulopathy. (öffnet neues Fenster)

Fontaine MJ, Lazarchick J, Taylor S, Annibale D.

Quelle‎: J Perinatol 2004;24(5):310-1.

Indiziert‎: PubMed 15116125

DOI‎: 10.1038/sj.jp.7211086

https://www.ncbi.nlm.nih.gov/pubmed/15116125 (öffnet neues Fenster)

Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances. (öffnet neues Fenster)

Gkiougki E, Mitsiakos G, Chatziioannidis E, Papadakis E, Nikolaidis N.

Quelle‎: J Pediatr Hematol Oncol 2013;35(3):221-6.

Indiziert‎: PubMed 23511491

DOI‎: 10.1097/MPH.0b013e318286d27e

https://www.ncbi.nlm.nih.gov/pubmed/23511491 (öffnet neues Fenster)

Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage. (öffnet neues Fenster)

Grizelj R, Vuković J, Filipović-Grčić B, Šarić D, Luetić T.

Quelle‎: Blood Coagul Fibrinolysis 2006;17(5):413-5.

Indiziert‎: PubMed 16788319

DOI‎: 10.1097/01.mbc.0000233373.71970.6f

https://www.ncbi.nlm.nih.gov/pubmed/16788319 (öffnet neues Fenster)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (öffnet neues Fenster)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Quelle‎: Paediatr Anaesth 2009;19(4):364-70.

Indiziert‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (öffnet neues Fenster)

The use of recombinant factor VIIa for severe intractable bleeding during spine surgery. (öffnet neues Fenster)

Kaw LL Jr, Coimbra R, Potenza BM, Garfin SR, Hoyt DB.

Quelle‎: Spine 2004;29(12):1384-7.

Indiziert‎: PubMed 15187645

https://www.ncbi.nlm.nih.gov/pubmed/15187645 (öffnet neues Fenster)

Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. (öffnet neues Fenster)

Mitsiakos G, Papaioannou G, Giougi E, Karagianni P, Garipidou V, Nikolaidis N.

Quelle‎: J Pediatr Hematol Oncol 2007;29(3):145-50.

Indiziert‎: PubMed 17356391

DOI‎: 10.1097/MPH.0b013e3180335bcb

https://www.ncbi.nlm.nih.gov/pubmed/17356391 (öffnet neues Fenster)

Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. (öffnet neues Fenster)

Olomu N, Kulkarni R, Manco-Johnson M.

Quelle‎: J Perinatol 2002;22(8):672-4.

Indiziert‎: PubMed 12478454

DOI‎: 10.1038/sj.jp.7210787

https://www.ncbi.nlm.nih.gov/pubmed/12478454 (öffnet neues Fenster)

Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. (öffnet neues Fenster)

Puetz J, Darling G, Brabec P, Blatny J, Mathew P.

Quelle‎: Pediatr Blood Cancer 2009;53(6):1074-8.

Indiziert‎: PubMed 19621430

DOI‎: 10.1002/pbc.22160

https://www.ncbi.nlm.nih.gov/pubmed/19621430 (öffnet neues Fenster)